Funded equally by LUNGevity Foundation and the Illinois Chapter of the American Cancer Society
Dwight Seferos, PhD
Northwestern University Department of Chemistry
Chicago
Dr. Seferos is developing new nanoparticle-based agents that are 13 nanometers in diameter to treat lung cancer. Unlike traditional chemotherapy, these particles can target the cancer cells directly and so reduce the side effects that are commonly associated with chemotherapy.